Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Leela Morena"'
1
Akademický článek
Safety and Efficacy of a Preemptive Mycophenolate Mofetil Dose Reduction Strategy in Kidney Transplant Recipients
Autor: Karim Yatim, MD, Ayman Al Jurdi, MD, Christopher El Mouhayyar, MD, Leela Morena, MD, Frank E. Hullekes, MD, Ruchama Verhoeff, MD, Guilherme T. Ribas, MSc, Daniel S. Pearson, MD, PhD, Leonardo V. Riella, MD, PhD, FASN
Publikováno v: Transplantation Direct, Vol 10, Iss 9, p e1697 (2024)
Background. There are no high-quality data to guide long-term mycophenolate mofetil (MMF) dosing in kidney transplant recipients (KTRs) to balance the long-term risks of allograft rejection with that of infections and malignancy. At our center, KTRs
Externí odkaz: https://doaj.org/article/9d65cc3769a64372a1ab600032708d61
Zobrazit plný text záznamu
3
Urbanization and kidney dysfunction in Brazilian indigenous people: a burden for the youth
Autor: Orlando Vieira Gomes, Manoel Pereira Guimarães, Jandir Mendonça Nicacio, Leela Morena, Antônio Marconi Leandro da Silva, Jeová Cordeiro de Morais Junior, Carlos Dornels Freire de Souza, Manoel Barral Netto, João Augusto Costa Lima, Anderson da Costa Armstrong
Publikováno v: Revista da Associação Médica Brasileira, Volume: 69, Issue: 2, Pages: 240-245, Published: 03 MAR 2023
SUMMARY OBJECTIVE: The aim of this study was to investigate whether the degree of urbanization influences the prevalence of chronic kidney disease in Brazilian indigenous people. METHODS: This is a cross-sectional study conducted between 2016 and 201
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c79eb6b2010683ff644bf36ba4e0d1f
https://doi.org/10.1590/1806-9282.20220934
Zobrazit plný text záznamu
5
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the Omicron wave
Autor: Ayman Al Jurdi, Leela Morena, Mariesa Cote, Emily Bethea, Jamil Azzi, Leonardo V. Riella
The neutralizing monoclonal antibody combination of tixagevimab/cilgavimab has been shown to reduce the risk of SARS-CoV-2 infection in unvaccinated individuals during the Alpha (B.1.1.7) and Delta (B.1.617.2) waves. However, data on the efficacy and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea01884b52d3ce4a988a16d4948bc32a
https://doi.org/10.1101/2022.05.17.22274980
Zobrazit plný text záznamu
6
Akademický článek
Post–acute Sequelae of COVID-19 Among Solid Organ Transplant Recipients: Insights From the Omicron Period
Autor: Leela Morená, MD, Ayman Al Jurdi, MD, Christopher El Mouhayyar, MD, Rucháma Verhoeff, MD, Nora Alzahrani, MD, Camille N. Kotton, MD, Leonardo V. Riella, MD, PhD, FASN
Publikováno v: Transplantation Direct, Vol 10, Iss 9, p e1690 (2024)
Background. In solid organ transplant recipients (SOTRs), studies investigating post–acute sequelae of SARS-CoV-2 infection (PASC) are limited, and risk factors for their development require further investigation. Methods. In this cross-sectional s
Externí odkaz: https://doaj.org/article/11ee1d1e521047f89375e986c0f17ea7
Zobrazit plný text záznamu
9
Akademický článek
The value of pre-transplant coronary angiography findings in kidney transplant candidates at high risk for cardiovascular disease
Autor: Leela Morená, Ayman Al Jurdi, Eduardo Leal Adam, Rucháma Verhoeff, Ragnar Palsson, Guilherme Taborda Ribas, Frank Hullekes, Abraham Cohen Bucay, Nahel Elias, Leonardo. V. Riella
Publikováno v: Frontiers in Transplantation, Vol 2 (2023)
IntroductionCardiovascular disease is a significant cause of mortality after kidney transplantation. Whether pre-transplant screening for coronary artery disease (CAD) in asymptomatic kidney transplant candidates (KTCs) is beneficial is unclear.Metho
Externí odkaz: https://doaj.org/article/71f5bdc6f1dc4855999013c006999eba
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje